Department of Hematology, Ankara Oncology Research and Education Hospital, Ankara University School of Medicine, Ankara, Turkey.
Cytotherapy. 2010;12(1):38-44. doi: 10.3109/14653240903313958.
Mesenchymal stromal cells (MSC) are the most popular cells used in regenerative medicine and biotechnology. The clonogenic potential of these cells is defined by colony-forming unit-fibroblasts (CFU-F). It is well known that there is an interaction between hematopoietic cells and stromal cells in disease formation pathogenesis. Therefore we hypothesized that there should be a quantitative and qualitative relationship between MSC colonies (CFU-F) and hematopoietic stem cell colonies (colony-forming unit-granulocyte-macrophages; CFU-GM) among patients with and without hematologic diseases.
Forty-two patients were included in this study. Patients were divided into three groups: group A, patients with hematologic malignancies (n =20); group B, patients with bone marrow (BM) failure (n =11); group C, patients without hematologic diseases (n =11). BM aspirates were plated in different densities for CFU-F culture. The plating density was the same for CFU-GM culture.
CFU-GM colonies grew in 90% of group A cells and all of group B and C cells (P= 0.0001). CFU-F colonies became visible on the ninth day of plating in group A and on the eight day in groups B and C. There was no statistically significant difference between the groups for the duration of CFU-F colony formation (P= 0.12). There were differences in the morphology of the colonies among the groups.
This is the first study that has compared the clonogenic potential of stromal cells and hematopoietic stem cells in the same subjects with and without hematologic diseases. No correlation was shown between the clonogenic potential of stromal cells and hematopoietic cells.
间充质基质细胞(MSC)是再生医学和生物技术中最常用的细胞。这些细胞的集落形成能力由成纤维细胞集落形成单位(CFU-F)定义。众所周知,在疾病形成发病机制中,造血细胞与基质细胞之间存在相互作用。因此,我们假设在有和没有血液疾病的患者中,MSC 集落(CFU-F)和造血干细胞集落(粒细胞-巨噬细胞集落形成单位;CFU-GM)之间应该存在数量和质量上的关系。
本研究纳入了 42 名患者。患者分为三组:A 组,血液恶性肿瘤患者(n=20);B 组,骨髓(BM)衰竭患者(n=11);C 组,无血液疾病患者(n=11)。BM 抽吸物以不同密度接种于 CFU-F 培养。CFU-GM 培养的接种密度相同。
A 组 90%的细胞和 B 组和 C 组所有细胞均可见 CFU-GM 集落生长(P=0.0001)。A 组 CFU-F 集落于第 9 天可见,B 组和 C 组于第 8 天可见。各组 CFU-F 集落形成时间无统计学差异(P=0.12)。各组集落形态存在差异。
这是第一项在有和没有血液疾病的同一受试者中比较基质细胞和造血干细胞集落形成能力的研究。未显示基质细胞和造血细胞的集落形成能力之间存在相关性。